Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Five mega projects to help reposition the UFS
2008-02-01

The University of the Free State (UFS) today announced that it will focus on five mega-projects to help reposition the UFS in the next five years as one of South Africa’s leading universities that is successfully managing excellence and diversity.

Speaking at the official opening of the university today, the Rector and Vice-Chancellor, Prof. Frederick Fourie, identified the five mega projects as:

  • The successful implementation of strategic academic clusters to focus the teaching and research expertise of the UFS.
  • The development and implementation of new models of teaching and learning.
  • Finding new sources of income (including third-stream income) to minimise dependence on government subsidies and tuition fees.
  • Creating a new institutional culture for the university by finalising the Institutional Charter.
  • The ongoing transformation of the UFS in all its dimensions.

According to Prof. Fourie, the strategic clusters – initiated in 2006 – are a very important initiative which is aimed at making the UFS a world leader in six broad areas. The focus of the six clusters has now been determined. These clusters are not just research based, but will include postgraduate programmes and filter down to undergraduate learning programmes and curricula.

He also indicated that other research at the UFS will continue to be supported and funded as before.

The second project, to establish a new teaching and learning model, is meant to address current success rates which indicate the need for this issue to receive a high priority.

New income streams to enable higher levels of financial sustainability is the third project, especially in view of dwindling government subsidies and limits on student numbers. This is necessary to fund sustained higher levels of investment in the quality of academic activities and in the necessary capacity and facilities.

Prof. Fourie said the fourth project regarding institutional culture is an ongoing effort to create a sense of belonging for all staff and students at the UFS through the adoption of an Institutional Charter for the university.

“What the draft Charter does – in addition to describing overarching values espoused by the institution and its people – is to describe the outlines and constitutive principles of the ‘post-redress’ UFS,” said Prof. Fourie.

The Charter – initially launched in 2007 – is and remains a critical element of guiding transformation effectively and speedily towards a widely-accepted goal. It is a critical element of the “social sustainability and robustness” of a new UFS, especially in tumultuous political times.

The fifth project is the Transformation Plan, launched in 2007. “We simply must pursue this plan diligently, given our commitment to comprehensive and deep transformation, and to best practice transformation. All universities will have to face up to the challenge of transformation and the UFS can break new ground, as it did in the past by managing transformation innovatively and creating a campus where all can find their rightful place,” said Prof. Fourie.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
1 February 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept